Other names: Tresiba
Categories: Prescription Medication
Description:
Tresiba (insulin degludec) is an ultra-long-acting basal insulin used to manage blood sugar in people with type 1 and type 2 diabetes. It provides a steady release of insulin for over 42 hours, allowing for flexible once-daily dosing at different times of day without losing effectiveness. Tresiba starts working within 1–2 hours and has no significant peak, which helps lower the risk of hypoglycemia. It is often used alongside rapid-acting insulin or other diabetes medications. Tresiba is available in prefilled pens and comes in multiple strengths, including U-100 and U-200.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the effectiveness of Insulin degludec in treating Type 1 Diabetes. The author has not provided any review or rating for this treatment. Therefore, it is not possible to determine the effectiveness of Insulin degludec for Type 1 Diabetes based on the given data.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
